All companies
Visit website
QMed Innovations
OperatingQ Med Innovations, Inc.
Healthcare · Technology · Founded 2019
Game chaning data and analytics for medical device manufacturers, distributors and providers
Post-money valuation ⓘ
$14.8M
As of Nov 2023 · from QMed Innovations Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$600
Across 1 round since 2023
Latest share price
$0.20
QMed Innovations Common Stock 1 offering price
Financials
FY2021–FY2022 · from SEC filings · hover any figure for its source$17K
−$1.7M
2021
$57K
−$3.1M
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
Income statement
Revenue
$16,820
$57,278
Cost of goods sold
$8,935
$11,180
Gross margin
47%
80%
Net income
-$1,694,694
-$3,117,138
Taxes paid
$0
$0
Balance sheet
Cash
$2,282,254
$163,205
Accounts receivable
$36,312
$38,797
Total assets
$2,832,770
$1,381,117
Short-term debt
$58,994
$27,358
Long-term debt
$41,006
$61,424
Total liabilities
$100,000
$88,782
Other
Headcount
—
8
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$14.8M
post-money
QMed Innovations Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $600 / $1.2MPost-money $14.8M
Reg CF annual-report compliance
Not obligated
never closed a Reg CF raise
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
- Form CSep 6, 20230001669191-23-000871EDGAR
Source: ManualCIK 0001984635Share price $0.20
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.